BOSE PUBLIC AFFAIRS GROUP

Lobbying for ASSOCIATION FOR PRESCRIPTION PSYCHEDELICS · Industry association representing pharmaceutical companies

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · New York · House · Senate · $37,500.00 income · posted Jul 20, 2026

Lobbying activity 1

Health Issues

FDA approval and regulation of prescription psychedelic therapies

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.